News and Announcements
Sirona Capital Offers Update on Business Activities April 2017
- Published April 06, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Sirona Insider each quarter offers a brief update on their company’s business activities. It features many of the investment or development projects also highlighting how Sirona engages with the communities in which they operate.
KEY TAKEAWAYS:
Hotels and Tourism
- Their most recent opening of the new Quest Apartment Hotel in Fremantle was a milestone event for Sirona. It represented the culmination and realisation for the company in relation to the hotel and tourism sector.
- Sirona has recently entered into a partnership with Rotana, the Middle East’s leading hotel operator, to deliver a new business hotel brand into the Australian market.
- Rotana operates over 100 hotels and is closely associated with Emirates, Etihad and Qatar Airways.
- Sirona expect to secure our first development with Rotana this year, having already identified an appropriate site in Perth’s CBD.
Falls Festival
- Kings Square in Fremantle held the first WA Falls Festival on 7-8 February, dubbed “Falls Downtown”. Falls Festival has been running in the Eastern states for the past 13 years.
Staff Profile
- As Sirona completes high-quality development projects such as the Quest Hotel and Heirloom Apartments, and initiates others like the $270 million Kings Square project in Fremantle, the company feels “fortunate” to have Jeff Holloway join Sirona to head up our development management team and activities.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
